# Lipid Mediators & Cancer: Montelukast, SPM, and Almonds

> **NCT06887673** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **University of South Florida** · enrollment: 56 (estimated)

## Conditions studied

- Colorectal Cancer
- Sarcoma
- Brain Tumors
- Endometrial Cancer
- Ovarian Cancer

## Interventions

- **OTHER:** No Interventions
- **DIETARY_SUPPLEMENT:** Sports Pro Resolve 4 g
- **DIETARY_SUPPLEMENT:** Double Wood SPM 4 g
- **DIETARY_SUPPLEMENT:** 20 California Sweet Almonds
- **DRUG:** Montelukast 10 Mg Oral Tablet
- **COMBINATION_PRODUCT:** Montelukast 10 Mg Oral Tablet and SPM 4 g
- **DIETARY_SUPPLEMENT:** Cold- Pressed Almond Oil 30 mL

## Key facts

- **NCT ID:** NCT06887673
- **Lead sponsor:** University of South Florida
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03
- **Primary completion:** 2026-03
- **Final completion:** 2026-03
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2025-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06887673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06887673, "Lipid Mediators & Cancer: Montelukast, SPM, and Almonds". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06887673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*